David Moore

Mr. David S.
Moore is a Senior Partner at ARCH Venture Partners LLC, an Independent Director at Corvus Pharmaceuticals, Inc. and a Chairman at Novasenta, Inc. He is on the Board of Directors at Corvus Pharmaceuticals, Inc., Corium LLC (Massachusetts) and Tremeau Pharmaceuticals, Inc. Mr. Moore was previously employed as a Partner by Gurnet Point Capital LLC, a Chief Executive Officer by Roivant Sciences, Inc., a Senior Vice President-US Commercial by Novo Nordisk, Inc., a President & Chief Commercial Officer by Cempra, Inc., an Independent Director by Sirona Biochem Corp., a Chief Business Officer by OCERA Therapeutics LLC, and a Chief Business Officer by Tranzyme Pharma, Inc. (Canada).
He also served on the board at Alladapt Immunotherapeutics, Inc. He received his undergraduate degree from Thomas Jefferson University, an undergraduate degree from Towson University and an MBA from Lehigh University.